메뉴 건너뛰기




Volumn 10, Issue 10, 2015, Pages

Serum IL-10 predicts worse outcome in cancer patients: A meta-analysis

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR MARKER; IL10 PROTEIN, HUMAN;

EID: 84947721328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139598     Document Type: Article
Times cited : (127)

References (58)
  • 1
    • 17644394616 scopus 로고    scopus 로고
    • Smoldering and polarized inflammation in the initiation and promotion of Malignant disease
    • PMID: 15766659
    • Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer cell. 2005; 7(3):211-7. doi:10.1016/j.ccr.2005.02.013 PMID: 15766659.
    • (2005) Cancer Cell , vol.7 , Issue.3 , pp. 211-217
    • Balkwill, F.1    Charles, K.A.2    Mantovani, A.3
  • 2
    • 0035901090 scopus 로고    scopus 로고
    • Inflammation and cancer: Back to virchow?
    • PMID: 11229684
    • Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001; 357(9255):539-45. doi:10.1016/S0140-6736(00)04046-0 PMID: 11229684.
    • (2001) Lancet , vol.357 , Issue.9255 , pp. 539-545
    • Balkwill, F.1    Mantovani, A.2
  • 3
    • 0037180757 scopus 로고    scopus 로고
    • Inflammation and cancer
    • PMID: 12490959; PubMed Central PMCID: PMC2803035
    • Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917):860-7. doi:10.1038/nature01322 PMID: 12490959; PubMed Central PMCID: PMC2803035.
    • (2002) Nature , vol.420 , Issue.6917 , pp. 860-867
    • Coussens, L.M.1    Werb, Z.2
  • 4
    • 33745298519 scopus 로고    scopus 로고
    • Nuclear factor-kappaB in cancer development and progression
    • PMID: 16724054
    • Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006; 441 (7092):431-6. doi:10.1038/nature04870 PMID: 16724054.
    • (2006) Nature , vol.441 , Issue.7092 , pp. 431-436
    • Karin, M.1
  • 5
    • 47949096781 scopus 로고    scopus 로고
    • Cancer-related inflammation
    • PMID: 18650914
    • Mantovani A, Allavena P, Sica A., Balkwill F. Cancer-related inflammation. Nature. 2008; 454 (7203):436-44. doi:10.1038/nature07205 PMID: 18650914.
    • (2008) Nature , vol.454 , Issue.7203 , pp. 436-444
    • Mantovani, A.1    Allavena, P.2    Sica, A.3    Balkwill, F.4
  • 6
    • 31344466956 scopus 로고    scopus 로고
    • Chronic inflammation, immunosuppression and cancer: New insights and outlook
    • PMID: 16420981
    • Baniyash M. Chronic inflammation, immunosuppression and cancer: new insights and outlook. Seminars in cancer biology. 2006; 16(1):80-8. doi:10.1016/j.semcancer.2005.12.002 PMID: 16420981.
    • (2006) Seminars in Cancer Biology , vol.16 , Issue.1 , pp. 80-88
    • Baniyash, M.1
  • 7
    • 9644278053 scopus 로고    scopus 로고
    • Cytokines in cancer immunity and immunotherapy
    • PMID: 15546400
    • Smyth MJ, Cretney E, Kershaw M.H., Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunological reviews. 2004; 202:275-93. doi:10.1111/j.0105-2896.2004.00199.x PMID: 15546400.
    • (2004) Immunological Reviews , vol.202 , pp. 275-293
    • Smyth, M.J.1    Cretney, E.2    Kershaw, M.H.3    Hayakawa, Y.4
  • 8
    • 0036694663 scopus 로고    scopus 로고
    • Regulation of cytokine signaling and inflammation
    • PMID: 12220554
    • Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine & growth factor reviews. 2002; 13(4-5):413-21. PMID: 12220554.
    • (2002) Cytokine & Growth Factor Reviews , vol.13 , Issue.4-5 , pp. 413-421
    • Hanada, T.1    Yoshimura, A.2
  • 9
    • 74949093638 scopus 로고    scopus 로고
    • Role of CSF-1 in progression of epithelial ovarian cancer
    • PMID: 19903070; PubMed Central PMCID: PMC2830097
    • Chambers SK. Role of CSF-1 in progression of epithelial ovarian cancer. Future oncology. 2009; 5 (9):1429-40. doi:10.2217/fon.09.103 PMID: 19903070; PubMed Central PMCID: PMC2830097.
    • (2009) Future Oncology , vol.5 , Issue.9 , pp. 1429-1440
    • Chambers, S.K.1
  • 10
    • 0035936797 scopus 로고    scopus 로고
    • The TNF and TNF receptor superfamilies: Integrating Mammalian biology
    • PMID: 11239407
    • Locksley RM, Killeen N, Lenardo MJ The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001; 104(4):487-501. PMID: 11239407.
    • (2001) Cell. , vol.104 , Issue.4 , pp. 487-501
    • Locksley, R.M.1    Killeen, N.2    Lenardo, M.J.3
  • 11
    • 0036375050 scopus 로고    scopus 로고
    • Interleukin-1 - A major pleiotropic cytokine in tumor-host interactions
    • PMID: 12147202
    • Apte RN, Voronov E. Interleukin-1 - a major pleiotropic cytokine in tumor-host interactions. Seminars in cancer biology. 2002; 12(4):277-90. PMID: 12147202.
    • (2002) Seminars in Cancer Biology , vol.12 , Issue.4 , pp. 277-290
    • Apte, R.N.1    Voronov, E.2
  • 12
    • 84855867670 scopus 로고    scopus 로고
    • Targeting the fas/FasL signaling pathway in cancer therapy
    • PMID: 22239437
    • Villa-Morales M., Fernandez-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert opinion on therapeutic targets. 2012; 16(1):85-101. doi:10.1517/14728222.2011.628937 PMID: 22239437.
    • (2012) Expert Opinion on Therapeutic Targets , vol.16 , Issue.1 , pp. 85-101
    • Villa-Morales, M.1    Fernandez-Piqueras, J.2
  • 13
    • 84855880717 scopus 로고    scopus 로고
    • Targeting the VEGF signaling pathway in cancertherapy
    • PMID: 22239434
    • Waldner MJ, Neurath MF Targeting the VEGF signaling pathway in cancertherapy. Expert opinion on therapeutic targets. 2012; 16(1):5-13. doi:10.1517/14728222.2011.641951 PMID: 22239434.
    • (2012) Expert Opinion on Therapeutic Targets , vol.16 , Issue.1 , pp. 5-13
    • Waldner, M.J.1    Neurath, M.F.2
  • 14
    • 84893867951 scopus 로고    scopus 로고
    • TGF-beta: Duality of function between tumor prevention and carcinogenesis
    • PMID: 24511106; PubMed Central PMCID: PMC3952197
    • Principe DR, Doll JA, Bauer J, Jung B., Munshi HG, Bartholin L, et al. TGF-beta: duality of function between tumor prevention and carcinogenesis. Journal of the National Cancer Institute. 2014; 106(2): djt369. doi:10.1093/jnci/djt369 PMID: 24511106; PubMed Central PMCID: PMC3952197.
    • (2014) Journal of the National Cancer Institute , vol.106 , Issue.2
    • Principe, D.R.1    Doll, J.A.2    Bauer, J.3    Jung, B.4    Munshi, H.G.5    Bartholin, L.6
  • 15
    • 34548131112 scopus 로고    scopus 로고
    • RegulatoryTcells expressing interleukin 10 develop from foxp3+ and foxp3- precursor cells in the absence of interleukin 10
    • PMID: 17694059
    • Maynard CL, Harrington LE, Janowski K.M., Oliver JR, Zindl CL, Rudensky AY, et al RegulatoryTcells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nature immunology. 2007; 8(9):931-41. doi:10.1038/ni1504 PMID: 17694059.
    • (2007) Nature Immunology , vol.8 , Issue.9 , pp. 931-941
    • Maynard, C.L.1    Harrington, L.E.2    Janowski, K.M.3    Oliver, J.R.4    Zindl, C.L.5    Rudensky, A.Y.6
  • 16
    • 0027204621 scopus 로고
    • Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2)T cell clones and inhibits their antigen-specific proliferation and cytokine production
    • Baltimore, Md PMID: 8419468
    • Del Prete G., De Carli M, Almerigogna F, Giudizi M.G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2)T cell clones and inhibits their antigen-specific proliferation and cytokine production. Journal of immunology (Baltimore, Md: 1950). 1993; 150 (2):353-60. PMID: 8419468.
    • (1950) Journal of Immunology , vol.150 , Issue.2 , pp. 353-360
    • Del Prete, G.1    De Carli, M.2    Almerigogna, F.3    Giudizi, M.G.4    Biagiotti, R.5    Romagnani, S.6
  • 17
    • 0024408824 scopus 로고
    • Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production byTh1 clones
    • PMID: 2531194; PubMed Central PMCID: PMC2189521
    • Fiorentino DF, Bond MW, Mosmann TR Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production byTh1 clones. The Journal of experimental medicine. 1989; 170 (6):2081-95. PMID: 2531194; PubMed Central PMCID: PMC2189521.
    • (1989) The Journal of Experimental Medicine , vol.170 , Issue.6 , pp. 2081-2095
    • Fiorentino, D.F.1    Bond, M.W.2    Mosmann, T.R.3
  • 21
    • 84885433913 scopus 로고    scopus 로고
    • Current status of interleukin-10 and regulatory T-cells in cancer
    • Epub 2013/10/01 PMID: 24076584
    • Dennis KL, Blatner NR, Gounari F, Khazaie K. Current status of interleukin-10 and regulatory T-cells in cancer. Current opinion in oncology. 2013; 25(6):637-45. Epub 2013/10/01. doi:10.1097/cco.0000000000000006 PMID: 24076584.
    • (2013) Current Opinion in Oncology , vol.25 , Issue.6 , pp. 637-645
    • Dennis, K.L.1    Blatner, N.R.2    Gounari, F.3    Khazaie, K.4
  • 22
    • 84860341228 scopus 로고    scopus 로고
    • Role of interleukin-10 in breast cancer
    • Epub 2011/11/08 PMID: 22057973
    • Hamidullah, Changkija B, Konwar R. Role of interleukin-10 in breast cancer. Breast cancer research and treatment. 2012; 133(1):11-21. Epub 2011/11/08. doi:10.1007/s10549-011-1855-x PMID: 22057973.
    • (2012) Breast Cancer Research and Treatment , vol.133 , Issue.1 , pp. 11-21
    • Hamidullah1    Changkija, B.2    Konwar, R.3
  • 23
    • 84856541896 scopus 로고    scopus 로고
    • Interleukin 10 in the tumor micro-environment: A target for anticancer immunotherapy
    • Epub 2011/12/06 PMID: 22139852
    • Sato T, Terai M, Tamura Y., Alexeev V, Mastrangelo MJ, Selvan SR Interleukin 10 in the tumor micro-environment: a target for anticancer immunotherapy. Immunologic research. 2011; 51(2-3):170-82. Epub 2011/12/06. doi:10.1007/s12026-011-8262-6 PMID: 22139852.
    • (2011) Immunologic Research , vol.51 , Issue.2-3 , pp. 170-182
    • Sato, T.1    Terai, M.2    Tamura, Y.3    Alexeev, V.4    Mastrangelo, M.J.5    Selvan, S.R.6
  • 24
    • 9644302458 scopus 로고    scopus 로고
    • Interleukin-10 in viral diseases and cancer: Exiting the labyrinth?
    • Epub 2004/11/18 PMID: 15546396
    • Vicari AP, Trinchieri G. Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunological reviews. 2004; 202:223-36. Epub 2004/11/18. doi:10.1111/j.0105-2896.2004.00216.x PMID: 15546396.
    • (2004) Immunological Reviews , vol.202 , pp. 223-236
    • Vicari, A.P.1    Trinchieri, G.2
  • 25
    • 0029875958 scopus 로고    scopus 로고
    • Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer
    • PMID: 8606382
    • Kundu N, Beaty TL, Jackson M.J., Fulton AM. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. Journal of the National Cancer Institute. 1996; 88(8):536-41. PMID: 8606382.
    • (1996) Journal of the National Cancer Institute , vol.88 , Issue.8 , pp. 536-541
    • Kundu, N.1    Beaty, T.L.2    Jackson, M.J.3    Fulton, A.M.4
  • 28
    • 0038281412 scopus 로고    scopus 로고
    • High pretreatment interleukin-10 is an independent predictor of poor failure-free survival in patients with hodgkin's lymphoma
    • Epub 2003/06/14. PMID: 12803112
    • Salgami EV, Efstathiou SP, Vlachakis V, Sekara E.V., Syrigos KN, Roussou PP. High pretreatment interleukin-10 is an independent predictor of poor failure-free survival in patients with Hodgkin's lymphoma. Haematologia. 2002; 32(4):377-87. Epub 2003/06/14. PMID: 12803112.
    • (2002) Haematologia , vol.32 , Issue.4 , pp. 377-387
    • Salgami, E.V.1    Efstathiou, S.P.2    Vlachakis, V.3    Sekara, E.V.4    Syrigos, K.N.5    Roussou, P.P.6
  • 29
    • 4544339987 scopus 로고    scopus 로고
    • Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with hodgkin's disease treated with radiotherapy
    • Epub 2004/09/17 PMID: 15370254
    • Visco C, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S., Bonfante V, et al. Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy. Leukemia & lymphoma. 2004; 45(10):2085-92. Epub 2004/09/17. doi:10.1080/10428190410001712234 PMID: 15370254.
    • (2004) Leukemia & Lymphoma , vol.45 , Issue.10 , pp. 2085-2092
    • Visco, C.1    Vassilakopoulos, T.P.2    Kliche, K.O.3    Nadali, G.4    Viviani, S.5    Bonfante, V.6
  • 30
    • 3042511800 scopus 로고    scopus 로고
    • Clinical significance of thrombospon-din-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma
    • PMID: MEDLINE:12963968
    • Kaio E, Tanaka S, Oka S., Hiyama T, Kitadai Y, Haruma K., et al. Clinical significance of thrombospon-din-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma. International journal of oncology. 2003; 23(4):901-11. PMID: MEDLINE:12963968.
    • (2003) International Journal of Oncology , vol.23 , Issue.4 , pp. 901-911
    • Kaio, E.1    Tanaka, S.2    Oka, S.3    Hiyama, T.4    Kitadai, Y.5    Haruma, K.6
  • 32
    • 76849084918 scopus 로고    scopus 로고
    • Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma
    • PMID: MEDLINE:20037839
    • Toiyama Y, Miki C, Inoue Y., Minobe S, Urano H, Kusunoki M. Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma. Surgery today. 2010; 40(1):46-53. doi:10.1007/s00595-009-4016-7 PMID: MEDLINE:20037839.
    • (2010) Surgery Today , vol.40 , Issue.1 , pp. 46-53
    • Toiyama, Y.1    Miki, C.2    Inoue, Y.3    Minobe, S.4    Urano, H.5    Kusunoki, M.6
  • 33
    • 67349098558 scopus 로고    scopus 로고
    • Human interleukin 10 receptor 1/IgG1-fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
    • PMID: 19142637
    • Terai M, Tamura Y, Alexeev V., Ohtsuka E, Berd D, Mastrangelo M.J., et al. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential. Cancer immunology, immunotherapy: CII. 2009; 58(8):1307-17. doi:10.1007/s00262-008-0644-9 PMID: 19142637.
    • (2009) Cancer Immunology, Immunotherapy: CII , vol.58 , Issue.8 , pp. 1307-1317
    • Terai, M.1    Tamura, Y.2    Alexeev, V.3    Ohtsuka, E.4    Berd, D.5    Mastrangelo, M.J.6
  • 34
    • 0029070119 scopus 로고
    • A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses
    • Baltimore, Md 1995 PMID: 7730651
    • Chernoff AE, Granowitz EV, Shapiro L, Vannier E., Lonnemann G, Angel JB, et al A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. Journal of immunology (Baltimore, Md: 1950). 1995; 154(10):5492-9. PMID: 7730651.
    • (1950) Journal of Immunology , vol.154 , Issue.10 , pp. 5492-5499
    • Chernoff, A.E.1    Granowitz, E.V.2    Shapiro, L.3    Vannier, E.4    Lonnemann, G.5    Angel, J.B.6
  • 35
    • 0037136303 scopus 로고    scopus 로고
    • Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody
    • PMID: 12186845; PubMed Central PMCID: PMC2196048
    • Vicari AP, Chiodoni C, Vaure C., Ait-Yahia S, Dercamp C, Matsos F., et al. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. The Journal of experimental medicine. 2002; 196(4):541-9. PMID: 12186845; PubMed Central PMCID: PMC2196048.
    • (2002) The Journal of Experimental Medicine , vol.196 , Issue.4 , pp. 541-549
    • Vicari, A.P.1    Chiodoni, C.2    Vaure, C.3    Ait-Yahia, S.4    Dercamp, C.5    Matsos, F.6
  • 36
    • 84879189270 scopus 로고    scopus 로고
    • Pegylated IL-10 induces cancer immunity: The surprising role of IL-10 as a potent inducer of IFN-gamma-mediated CD8(+) T cell cytotoxicity
    • Epub 2013/05/15 PMID: 23666891
    • Mumm JB, Oft M. Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-gamma-mediated CD8(+) T cell cytotoxicity. BioEssays: news and reviews in molecular, cellular and developmental biology. 2013; 35(7):623-31. Epub 2013/05/15. doi:10.1002/bies. 201300004 PMID: 23666891.
    • (2013) BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology , vol.35 , Issue.7 , pp. 623-631
    • Mumm, J.B.1    Oft, M.2
  • 37
    • 30944450549 scopus 로고    scopus 로고
    • Analysing and presenting results
    • Higgins JPT, Green S, ed 425 Chichester, UK: John Wiley & Sons ncer Res.
    • Deeks JJH. AD J. Analysing and presenting results. In: Higgins JPT, Green S, ed Cochrane Handbook for Systematic Reviews of Interventions 425 Chichester, UK: John Wiley & Sons ncer Res. 2006; 15: p. 6341-7.
    • (2006) Cochrane Handbook for Systematic Reviews of Interventions , vol.15 , pp. 6341-6347
    • Deeks, J.J.H.1    Ad, J.2
  • 38
    • 0027434991 scopus 로고
    • Serum interleukin-10 in non-hodgkin's lymphoma: A prognostic factor
    • Epub 1993/10/01. PMID: 8400266
    • Blay JY, Burdin N, Rousset F., Lenoir G, Biron P, Philip T., et al. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood. 1993; 82(7):2169-74. Epub 1993/10/01. PMID: 8400266.
    • (1993) Blood , vol.82 , Issue.7 , pp. 2169-2174
    • Blay, J.Y.1    Burdin, N.2    Rousset, F.3    Lenoir, G.4    Biron, P.5    Philip, T.6
  • 39
    • 0034034187 scopus 로고    scopus 로고
    • Poor clinical outcome of patients with hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for hodgkin's disease
    • Epub 2000/05/10. PMID: 10803931
    • Bohlen H, Kessler M, Sextro M., Diehl V, Tesch H. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease. Annals of hematology. 2000; 79(3):110-3. Epub 2000/05/10. PMID: 10803931.
    • (2000) Annals of Hematology , vol.79 , Issue.3 , pp. 110-113
    • Bohlen, H.1    Kessler, M.2    Sextro, M.3    Diehl, V.4    Tesch, H.5
  • 40
    • 84864651241 scopus 로고    scopus 로고
    • A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma
    • PMID: MEDLINE:22180222
    • Chan SL, Mo FKF, Wong CSC, Chan CML, Leung LKS, Hui EP, et al A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma. Cancer. 2012; 118(16):3984-92. doi:10.1002/cncr.26726 PMID: MEDLINE:22180222.
    • (2012) Cancer , vol.118 , Issue.16 , pp. 3984-3992
    • Chan, S.L.1    Mo, F.K.F.2    Wong, C.S.C.3    Chan, C.M.L.4    Leung, L.K.S.5    Hui, E.P.6
  • 41
    • 0028933071 scopus 로고
    • Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: Lack of correlation with prognosis
    • PMID: MEDLINE:7537119
    • Cortes JE, Talpaz M, Cabanillas F., Seymour JF, Kurzrock R. Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. Blood. 1995; 85(9):2516-20. PMID: MEDLINE:7537119.
    • (1995) Blood , vol.85 , Issue.9 , pp. 2516-2520
    • Cortes, J.E.1    Talpaz, M.2    Cabanillas, F.3    Seymour, J.F.4    Kurzrock, R.5
  • 42
    • 0033570973 scopus 로고    scopus 로고
    • Serum interleukin-10 levels in patients with advanced gastrointestinal Malignancies
    • PMID: MEDLINE: 10570416
    • De Vita F., Orditura M, Galizia G., Romano C, Infusino S, Auriemma A., et al. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer. 1999; 86(10):1936-43. doi: 10.1002/(sici)1097-0142(19991115)86:10<1936::aid-cncr9>3.0.co;2-9 PMID: MEDLINE: 10570416.
    • (1999) Cancer , vol.86 , Issue.10 , pp. 1936-1943
    • De Vita, F.1    Orditura, M.2    Galizia, G.3    Romano, C.4    Infusino, S.5    Auriemma, A.6
  • 43
    • 0033994349 scopus 로고    scopus 로고
    • Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
    • PMID: MEDLINE:10669676
    • De Vita F., Orditura M, Galizia G., Romano C, Roscigno A, Lieto E., et al. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest. 2000; 117(2):365-73. doi:10.1378/chest.117.2.365 PMID: MEDLINE:10669676.
    • (2000) Chest , vol.117 , Issue.2 , pp. 365-373
    • De Vita, F.1    Orditura, M.2    Galizia, G.3    Romano, C.4    Roscigno, A.5    Lieto, E.6
  • 44
    • 10044261013 scopus 로고    scopus 로고
    • Cytokines in pancreatic carcinoma: Correlation with phenotypic characteristics and prognosis
    • PMID: MEDLINE:15526319
    • Ebrahimi B, Tucker SL, Li D, Abbruzzese J.L., Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer. 2004; 101(12):2727-36. doi:10.1002/cncr. 20672 PMID: MEDLINE:15526319.
    • (2004) Cancer , vol.101 , Issue.12 , pp. 2727-2736
    • Ebrahimi, B.1    Tucker, S.L.2    Li, D.3    Abbruzzese, J.L.4    Kurzrock, R.5
  • 45
    • 33646849272 scopus 로고    scopus 로고
    • The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival
    • PMID: 20927906
    • Evans C, Morrison I, Heriot AG, Bartlett J.B., Finlayson C., Dalgleish AG, et al. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival. British journal of cancer. 2006; 94(10):1412-9. doi:10.1038/sj.bjc.6603104 PMID: 20927906.
    • (2006) British Journal of Cancer , vol.94 , Issue.10 , pp. 1412-1419
    • Evans, C.1    Morrison, I.2    Heriot, A.G.3    Bartlett, J.B.4    Finlayson, C.5    Dalgleish, A.G.6
  • 46
    • 0035160749 scopus 로고    scopus 로고
    • Interleukin-6and interleukin-10 levels in chronic lymphocytic leukemia: Correlation with phenotypic characteristics and outcome
    • PMID: MEDLINE:11133769
    • Fayad L, Keating MJ, Reuben J.M., O'Brien S, Lee BN, Lerner S, et al Interleukin-6and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood. 2001; 97(1):256-63. doi:10.1182/blood.V97.1.256 PMID: MEDLINE:11133769.
    • (2001) Blood , vol.97 , Issue.1 , pp. 256-263
    • Fayad, L.1    Keating, M.J.2    Reuben, J.M.3    O'Brien, S.4    Lee, B.N.5    Lerner, S.6
  • 47
    • 84857187863 scopus 로고    scopus 로고
    • Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients
    • PMID: MEDLINE:22075762
    • Green VL, Irune E, Prasai A., Alhamarneh O, Greenman J, Stafford ND Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients. International journal of oncology. 2012; 40(3):833-9. doi:10.3892/ijo.2011.1259 PMID: MEDLINE:22075762.
    • (2012) International Journal of Oncology , vol.40 , Issue.3 , pp. 833-839
    • Green, V.L.1    Irune, E.2    Prasai, A.3    Alhamarneh, O.4    Greenman, J.5    Stafford, N.D.6
  • 48
    • 0346895107 scopus 로고    scopus 로고
    • Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma
    • Hattori E, Okumoto K, Adachi T, Takeda T., Ito J-i, Sugahara K, et al Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma. Hepatology Research. 2003; 27(4):309.
    • (2003) Hepatology Research , vol.27 , Issue.4 , pp. 309
    • Hattori, E.1    Okumoto, K.2    Adachi, T.3    Takeda, T.4    Ito, J.-I.5    Sugahara, K.6
  • 49
    • 77952781844 scopus 로고    scopus 로고
    • Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-cell lymphoma in different risk groups defined by the international prognostic index
    • PMID: MEDLINE:20191326
    • Lech-Maranda E., Bienvenu J, Broussais-Guillaumot F, Warzocha K., Michallet A-S, Robak T, et al Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index. Archivum immunologiaeettherapiaeexperimentalis. 2010; 58(2):131-41. doi:10.1007/s00005-010-0066-1 PMID: MEDLINE:20191326.
    • (2010) Archivum Immunologiaeettherapiaeexperimentalis , vol.58 , Issue.2 , pp. 131-141
    • Lech-Maranda, E.1    Bienvenu, J.2    Broussais-Guillaumot, F.3    Warzocha, K.4    Michallet, A.-S.5    Robak, T.6
  • 50
    • 84872103461 scopus 로고    scopus 로고
    • Serum tumor necrosis factor-alpha and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status
    • PMID: MEDLINE:22945689
    • Lech-Maranda E., Grzybowska-Izydorczyk O, Wyka K., Mlynarski W, Borowiec M, Antosik K., et al. Serum tumor necrosis factor-alpha and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status. Archivum immunologiae ettherapiae experimentalis. 2012; 60(6):477-86. doi:10.1007/s00005-012-0197-7 PMID: MEDLINE:22945689.
    • (2012) Archivum Immunologiae Ettherapiae Experimentalis , vol.60 , Issue.6 , pp. 477-486
    • Lech-Maranda, E.1    Grzybowska-Izydorczyk, O.2    Wyka, K.3    Mlynarski, W.4    Borowiec, M.5    Antosik, K.6
  • 51
    • 43849092649 scopus 로고    scopus 로고
    • Correlation of serum IL-6, IL-8and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma
    • PMID: MEDLINE:18479302
    • Nacinovic-Duletic A., Stifter S, Dvornik S., Skunca Z, Jonjic N. Correlation of serum IL-6, IL-8and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. International journal of laboratory hematology. 2008; 30(3):230-9. doi:10.1111/j.1751-553X.2007. 00951.x PMID: MEDLINE:18479302.
    • (2008) International Journal of Laboratory Hematology , vol.30 , Issue.3 , pp. 230-239
    • Nacinovic-Duletic, A.1    Stifter, S.2    Dvornik, S.3    Skunca, Z.4    Jonjic, N.5
  • 52
    • 0035029602 scopus 로고    scopus 로고
    • Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma
    • PMID: MEDLINE:11338880
    • Nemunaitis J, Fong T, Shabe P., Martineau D, Ando D. Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma. Cancer investigation. 2001; 19 (3):239-47. doi:10.1081/cnv-100102550 PMID: MEDLINE:11338880.
    • (2001) Cancer Investigation , vol.19 , Issue.3 , pp. 239-247
    • Nemunaitis, J.1    Fong, T.2    Shabe, P.3    Martineau, D.4    Ando, D.5
  • 53
    • 75149137817 scopus 로고    scopus 로고
    • Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer
    • PMID: MEDLINE:20044609
    • Szaflarska A, Szczepanik A, Siedlar M, Czupryna A., Sierzega M, Popiela T, et al Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Anticancer research. 2009; 29(12):5005-12. PMID: MEDLINE:20044609.
    • (2009) Anticancer Research , vol.29 , Issue.12 , pp. 5005-5012
    • Szaflarska, A.1    Szczepanik, A.2    Siedlar, M.3    Czupryna, A.4    Sierzega, M.5    Popiela, T.6
  • 54
    • 0035074841 scopus 로고    scopus 로고
    • Serum interleukin-10 levels are an independent prognostic factor for patients with hodgkin's lymphoma
    • PMID: MEDLINE:11255274
    • Vassilakopoulos TP, Nadali G, Angelopoulou M.K., Siakantaris MP, Dimopoulou MN, Kontopidou FN, et al Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma. Haematologica. 2001; 86(3):274-81. PMID: MEDLINE:11255274.
    • (2001) Haematologica , vol.86 , Issue.3 , pp. 274-281
    • Vassilakopoulos, T.P.1    Nadali, G.2    Angelopoulou, M.K.3    Siakantaris, M.P.4    Dimopoulou, M.N.5    Kontopidou, F.N.6
  • 55
    • 0034059443 scopus 로고    scopus 로고
    • Elevated pretreatment serum levels of il-10 are associated with a poor prognosis in hodgkin's disease, the milan cancer institute experience
    • PMID: MEDLINE:10713662
    • Viviani S, Notti P, Bonfante V., Verderio P, Valagussa P, Bonadonna G. Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience. Medical oncology (Northwood, London, England). 2000; 17(1):59-63. doi:10.1007/bf02826218 PMID: MEDLINE:10713662.
    • (2000) Medical Oncology (Northwood, London, England) , vol.17 , Issue.1 , pp. 59-63
    • Viviani, S.1    Notti, P.2    Bonfante, V.3    Verderio, P.4    Valagussa, P.5    Bonadonna, G.6
  • 56
    • 0034028927 scopus 로고    scopus 로고
    • Serum interleukin-10butnotinterleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma
    • Epub 2000/04/05. PMID: 10749617; PubMed Central PMCID: PMCPmc1421032
    • Chau GY, Wu CW, Lui W.Y., Chang TJ, Kao HL, Wu LH, et al Serum interleukin-10butnotinterleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Annals of surgery. 2000; 231(4):552-8. Epub 2000/04/05. PMID: 10749617; PubMed Central PMCID: PMCPmc1421032.
    • (2000) Annals of Surgery , vol.231 , Issue.4 , pp. 552-558
    • Chau, G.Y.1    Wu, C.W.2    Lui, W.Y.3    Chang, T.J.4    Kao, H.L.5    Wu, L.H.6
  • 57
    • 0036176551 scopus 로고    scopus 로고
    • Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery
    • PMID: MEDLINE:11846459
    • Galizia G, Orditura M, Romano C, Lieto E., Castellano P, Pelosio L, et al Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clinical immunology (Orlando, Fla). 2002; 102(2):169-78. doi:10.1006/clim.2001.5163 PMID: MEDLINE:11846459.
    • (2002) Clinical Immunology (Orlando, Fla) , vol.102 , Issue.2 , pp. 169-178
    • Galizia, G.1    Orditura, M.2    Romano, C.3    Lieto, E.4    Castellano, P.5    Pelosio, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.